{"title":"礼来公司","authors":"","doi":"10.1002/div.7768","DOIUrl":null,"url":null,"abstract":"<p><b>Pharmaceuticals (MIC: SIC: 2834 NAIC: 325412)</b></p><p>Eli Lilly is engaged primarily in the discovery, development, manufacture, and sale of pharmaceutical products. Co.'s principal products are: Neurosciences products, which includes Zyprexa<sup>®</sup>, Strattera<sup>®</sup>, Prozac<sup>®</sup>, Cymbalta<sup>®</sup> and Symbyax<sup>®</sup>; Endocrinology products, including Humalog<sup>®</sup>, Humalog Mix 75/25<sup>®</sup>, and Humalog Mix 50/50<sup>®</sup>, Humulin<sup>®</sup>, Actos<sup>®</sup>, Byetta<sup>®</sup>, Evista<sup>®</sup>, Humatrope<sup>®</sup>, and Forteo<sup>®</sup>; Oncology products, including Gemzar<sup>®</sup> and Alimta<sup>®</sup>; Cardiovascular products, including Cialis<sup>®</sup>, ReoPro<sup>®</sup> and Xigris<sup>®</sup>; and other pharmaceutical products, including Vancocin<sup>®</sup> and Ceclor<sup>®</sup> . Co. also has an animal health segment.</p>","PeriodicalId":100917,"journal":{"name":"Mergent's Dividend Achievers","volume":"5 4","pages":"163"},"PeriodicalIF":0.0000,"publicationDate":"2008-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/div.7768","citationCount":"0","resultStr":"{\"title\":\"Lilly (Eli) & Co.†\",\"authors\":\"\",\"doi\":\"10.1002/div.7768\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><b>Pharmaceuticals (MIC: SIC: 2834 NAIC: 325412)</b></p><p>Eli Lilly is engaged primarily in the discovery, development, manufacture, and sale of pharmaceutical products. Co.'s principal products are: Neurosciences products, which includes Zyprexa<sup>®</sup>, Strattera<sup>®</sup>, Prozac<sup>®</sup>, Cymbalta<sup>®</sup> and Symbyax<sup>®</sup>; Endocrinology products, including Humalog<sup>®</sup>, Humalog Mix 75/25<sup>®</sup>, and Humalog Mix 50/50<sup>®</sup>, Humulin<sup>®</sup>, Actos<sup>®</sup>, Byetta<sup>®</sup>, Evista<sup>®</sup>, Humatrope<sup>®</sup>, and Forteo<sup>®</sup>; Oncology products, including Gemzar<sup>®</sup> and Alimta<sup>®</sup>; Cardiovascular products, including Cialis<sup>®</sup>, ReoPro<sup>®</sup> and Xigris<sup>®</sup>; and other pharmaceutical products, including Vancocin<sup>®</sup> and Ceclor<sup>®</sup> . Co. also has an animal health segment.</p>\",\"PeriodicalId\":100917,\"journal\":{\"name\":\"Mergent's Dividend Achievers\",\"volume\":\"5 4\",\"pages\":\"163\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-10-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1002/div.7768\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Mergent's Dividend Achievers\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/div.7768\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mergent's Dividend Achievers","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/div.7768","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Eli Lilly is engaged primarily in the discovery, development, manufacture, and sale of pharmaceutical products. Co.'s principal products are: Neurosciences products, which includes Zyprexa®, Strattera®, Prozac®, Cymbalta® and Symbyax®; Endocrinology products, including Humalog®, Humalog Mix 75/25®, and Humalog Mix 50/50®, Humulin®, Actos®, Byetta®, Evista®, Humatrope®, and Forteo®; Oncology products, including Gemzar® and Alimta®; Cardiovascular products, including Cialis®, ReoPro® and Xigris®; and other pharmaceutical products, including Vancocin® and Ceclor® . Co. also has an animal health segment.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
